Jeanne Marrazzo

Q: What Schools Are Affiliated With Jeanne Marrazzo

Jeanne Marrazzo is affiliated with the following schools: University of Alabama, University of Washington, University of Alabama at Birmingham

Jeanne Marrazzo's AcademicInfluence.com Rankings

Jeanne Marrazzo

Philosophy

#9984

World Rank

#13632

Historical Rank

#1806

USA Rank

Logic

#6924

World Rank

#8493

Historical Rank

#972

USA Rank

philosophy Degrees

Download Badge

Philosophy

Jeanne Marrazzo's Degrees

Doctorate Medicine University of Washington

Why Is Jeanne Marrazzo Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jeanne M. Marrazzo is an American physician-scientist and infectious diseases specialist. She is the director of the University of Alabama School of Medicine Division of Infectious Diseases and focuses on prevention of HIV infection using biomedical interventions. Marrazzo is also a fellow of the American College of Physicians and Infectious Disease Society of America. On August 2, 2023 Lawrence A. Tabak, acting director for the National Institutes of Health, named Jeanne M. Marrazzo as director of NIH’s National Institute of Allergy and Infectious Diseases.

(See a Problem?)

Jeanne Marrazzo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Molecular identification of bacteria associated with bacterial vaginosis. (2005) (1114)
Tenofovir-based preexposure prophylaxis for HIV infection among African women. (2015) (1081)
Bacterial Communities in Women with Bacterial Vaginosis: High Resolution Phylogenetic Analyses Reveal Relationships of Microbiota to Clinical Criteria (2012) (526)
Sexually transmitted infections: challenges ahead. (2017) (453)
Temporal Variability of Human Vaginal Bacteria and Relationship with Bacterial Vaginosis (2010) (369)
Targeted PCR for Detection of Vaginal Bacteria Associated with Bacterial Vaginosis (2007) (359)
Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. (2002) (263)
Diversity of Human Vaginal Bacterial Communities and Associations with Clinically Defined Bacterial Vaginosis (2008) (261)
Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. (2001) (253)
Performance and Cost‐Effectiveness of Selective Screening Criteria for Chlamydia trachomatis Infection in Women: Implications for a National Chlamydia Control Strategy (1997) (208)
Metabolic Signatures of Bacterial Vaginosis (2015) (195)
Sexual practices, risk perception and knowledge of sexually transmitted disease risk among lesbian and bisexual women. (2005) (165)
Genital human papillomavirus infection in women who have sex with women. (1998) (164)
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. (2021) (163)
Relationship of Specific Vaginal Bacteria and Bacterial Vaginosis Treatment Failure in Women Who Have Sex with Women (2008) (151)
Community-Based Urine Screening for Chlamydia trachomatis with a Ligase Chain Reaction Assay (1997) (143)
The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission (2019) (143)
Changes in Vaginal Bacterial Concentrations with Intravaginal Metronidazole Therapy for Bacterial Vaginosis as Assessed by Quantitative PCR (2009) (142)
Bacterial Vaginosis and the Cervicovaginal Immune Response (2014) (131)
HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel. (2014) (125)
Single‐Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea (2018) (123)
Head-to-Head Multicenter Comparison of DNA Probe and Nucleic Acid Amplification Tests for Chlamydia trachomatis Infection in Women Performed with an Improved Reference Standard (2002) (116)
An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women (2016) (111)
Interpreting the epidemiology and natural history of bacterial vaginosis: are we still confused? (2011) (106)
Bacterial Vaginosis: Identifying Research Gaps Proceedings of a Workshop Sponsored by DHHS/NIH/NIAID (2010) (101)
Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. (2012) (100)
Management of women with cervicitis. (2007) (99)
Genital human papillomavirus infection in women who have sex with women: a review. (2000) (92)
Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis. (2015) (90)
Barriers to Infectious Disease Care among Lesbians (2004) (89)
The Vaginal Microbiome: Current Understanding and Future Directions. (2016) (88)
The Program Cost and Cost-Effectiveness of Screening Men for Chlamydia to Prevent Pelvic Inflammatory Disease in Women (2008) (87)
Distribution of genital Lactobacillus strains shared by female sex partners. (2004) (84)
Risks for Acquisition of Bacterial Vaginosis Among Women Who Report Sex with Women: A Cohort Study (2010) (83)
Prevalence and Risks for Bacterial Vaginosis in Women Who Have Sex With Women (2010) (81)
Risk factors for cervicitis among women with bacterial vaginosis. (2006) (81)
Performance of Swabs, Lavage, and Diluents to Quantify Biomarkers of Female Genital Tract Soluble Mucosal Mediators (2011) (79)
Emerging Sexual Health Issues Among Women Who Have Sex with Women (2012) (74)
Prevalence of Chlamydia trachomatis Infection Among Men Screened in 4 U.S. Cities (2005) (74)
Chlamydia trachomatis infection among women reporting sexual activity with women screened in Family Planning Clinics in the Pacific Northwest, 1997 to 2005. (2011) (73)
Sexually transmitted infections among women who have sex with women. (2011) (73)
Predicting Chlamydial and Gonococcal Cervical Infection: Implications for Management of Cervicitis (2002) (72)
Prevalence and Risk Factors for Infection With Herpes Simplex Virus Type-1 and -2 Among Lesbians (2003) (71)
More Than Meets the Eye: Associations of Vaginal Bacteria with Gram Stain Morphotypes Using Molecular Phylogenetic Analysis (2013) (65)
Characteristics of female sexually transmitted disease clinic clients who report same-sex behaviour. (2001) (65)
Molecular methodology in determining vaginal flora in health and disease: Its time has come (2005) (65)
Barriers to Bacterial Sexually Transmitted Infection Testing of HIV-Infected Men Who Have Sex With Men Engaged in HIV Primary Care (2015) (62)
Urine-Based Screening for Chlamydia trachomatis in Men Attending Sexually Transmitted Disease Clinics (2001) (62)
Bacterial Vaginosis–Associated Bacteria in Men: Association of Leptotrichia/Sneathia spp. With Nongonococcal Urethritis (2013) (60)
Disclosure of pharmacokinetic drug results to understand nonadherence (2015) (60)
Within the Hidden Epidemic: Sexually Transmitted Diseases and HIV/AIDS Among American Indians and Alaska Natives (2007) (60)
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. (2015) (53)
Reproductive health history of lesbians: implications for care. (2004) (51)
Chlamydia trachomatis infection in asymptomatic men. (2003) (51)
Common Complementary and Alternative Therapies for Yeast Vaginitis and Bacterial Vaginosis: A Systematic Review (2003) (50)
Effectiveness of Two Tinidazole Regimens in Treatment of Bacterial Vaginosis: A Randomized Controlled Trial (2007) (49)
O11.1 Herpes Simplex Virus (HSV) Infection in the VOICE (MTN 003) Study: Pre-Exposure Prophylaxis (PrEP) For HIV with Daily Use of Oral Tenofovir, Oral Tenofovir-Emtricitabine, or Vaginal Tenofovir Gel (2013) (47)
Interventions to prevent sexually transmitted infections, including HIV infection. (2011) (47)
The Cost-Effectiveness of Screening Men for Chlamydia trachomatis: A Review of the Literature (2008) (46)
Selective screening for chlamydial infection in women: a comparison of three sets of criteria. (1997) (44)
A persistent(ly) enigmatic ecological mystery: bacterial vaginosis. (2006) (43)
Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis (2007) (41)
PrEParing Women to Prevent HIV: An Integrated Theoretical Framework to PrEP Black Women in the United States (2018) (40)
Implementation and Operational Research: Effectiveness and Patient Acceptability of a Sexually Transmitted Infection Self-Testing Program in an HIV Care Setting (2016) (40)
Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial (2018) (40)
Acceptability of Urine-Based Screening for Chlamydia trachomatis in Asymptomatic Young Men: A Systematic Review (2008) (39)
The Clinical and Economic Consequences of Screening Young Men for Genital Chlamydial Infection (2003) (39)
Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study (2016) (39)
Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis (2016) (38)
Mucopurulent cervicitis: no longer ignored, but still misunderstood. (2005) (38)
Ocular Syphilis: a Clinical Review (2016) (38)
Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. (2006) (37)
Sexually transmitted infections in women who have sex with women: who cares? (2000) (37)
Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study. (2016) (37)
A behavioural intervention to reduce persistence of bacterial vaginosis among women who report sex with women: results of a randomised trial (2011) (37)
Chlamydial Infections Among Female Adolescents Screened in Juvenile Detention Centers in Washington State, 1998–2002 (2006) (37)
Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women (2017) (36)
Evolving issues in understanding and treating bacterial vaginosis (2004) (36)
Population-Based Outreach for Chlamydia Screening in Men: Results From a Randomized Trial (2007) (36)
Behavioral Predictors of Colonization with Lactobacillus crispatus or Lactobacillus jensenii after Treatment for Bacterial Vaginosis: A Cohort Study (2012) (35)
Genital human papillomavirus infection in women who have sex with women: a concern for patients and providers. (2000) (34)
Re-evaluating Selective Screening Criteria for Chlamydial Infection Among Women in the U.S. Pacific Northwest (2004) (33)
Effect of Sexual Activity on Vaginal Colonization With Hydrogen Peroxide-Producing Lactobacilli and Gardnerella vaginalis (2011) (32)
Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial (2015) (32)
More Easily Cultivated Than Identified: Classical Isolation With Molecular Identification of Vaginal Bacteria. (2016) (31)
A multinational Delphi consensus to end the COVID-19 public health threat (2022) (31)
Relationship of Specific Bacteria in the Cervical and Vaginal Microbiotas With Cervicitis (2015) (31)
New approaches to the diagnosis, treatment, and prevention of chlamydial infection. (1998) (30)
Impact of Patient Characteristics on Performance of Nucleic Acid Amplification Tests and DNA Probe for Detection of Chlamydia trachomatis in Women with Genital Infections (2005) (30)
Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial. (2019) (27)
Antiviral Activity of Genital Tract Secretions After Oral or Topical Tenofovir Pre-exposure Prophylaxis for HIV-1 (2014) (25)
Prevalence of Neisseria gonorrhoeae Among Men Screened for Chlamydia trachomatis in Four United States Cities, 1999–2003 (2006) (25)
Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay (2015) (24)
A Prospective Cohort Study Comparing the Effect of Single-Dose 2 g Metronidazole on Trichomonas vaginalis Infection in HIV-Seropositive Versus HIV-Seronegative Women (2013) (24)
Functional Characterization of Class Ia- and Non-Class Ia-Restricted Chlamydia-Reactive CD8+ T Cell Responses in Humans 1 (2003) (23)
Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations. (2017) (23)
Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement (2018) (22)
Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women (2017) (22)
The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples. (2017) (22)
Women Who Have Sex with Women Living in Low- and Middle-Income Countries: A Systematic Review of Sexual Health and Risk Behaviors. (2015) (22)
Variations in Clinical Presentation of Ocular Syphilis: Case Series Reported From a Growing Epidemic in the United States. (2016) (22)
Recent advances in understanding and managing Chlamydia trachomatis infections (2014) (22)
Lesbian Health Matters: A Pap Test Education Campaign Nearly Thwarted by Discrimination (2004) (22)
Acceptability of Urine-Based Screening for Chlamydia trachomatis to Asymptomatic Young Men and Their Providers (2007) (22)
Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. (2012) (21)
Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis (2003) (20)
The Posttrial Effect of Oral Periodic Presumptive Treatment for Vaginal Infections on the Incidence of Bacterial Vaginosis and Lactobacillus Colonization (2012) (20)
Dangerous assumptions: lesbians and sexual death. (2005) (19)
Antiretroviral-based HIV prevention strategies for women (2010) (18)
Neisseria gonorrhoeae (Gonorrhea) (2015) (18)
Sexual tourism: implications for travelers and the destination culture. (2005) (17)
Vaginal biofilms and bacterial vaginosis: of mice and women. (2013) (17)
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis (2015) (17)
Chlamydia Positivity in Women Screened in Family Planning Clinics: Racial/Ethnic Differences and Trends in the Northwest U.S., 1997–2006 (2012) (17)
Diversity in the US Infectious Diseases Workforce: Challenges for Women and Underrepresented Minorities. (2017) (16)
Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial. (2015) (16)
Factors associated with bone mineral density in healthy African women (2015) (16)
Syphilis and other sexually transmitted diseases in HIV infection. (2007) (16)
Establishing and sustaining a healthy vaginal environment: analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections. (2011) (15)
Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit? (2016) (15)
Missed Prevention Opportunities: Why Young, Black MSM with Recent HIV Diagnosis did not Access HIV Pre-exposure Prophylaxis Services (2020) (14)
Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003) (2017) (14)
Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women (2015) (14)
Selective testing criteria for gonorrhea among young women screened for Chlamydial infection: contribution of race and geographic prevalence. (2007) (14)
Changes in Vaginal Bacterial Concentrations with Intravaginal Metronidazole Therapy for Bacterial Vaginosis as Assessed by Quantitative PCR (2007) (13)
Chlamydia Positivity in American Indian/Alaska Native Women Screened in Family Planning Clinics, 1997–2004 (2008) (13)
Perceptions and Experiences with the VOICE Adherence Strengthening Program (VASP) in the MTN-003 Trial (2015) (12)
Protection and Risk: Male and Female Genital Microbiota and Sexually Transmitted Infections. (2021) (12)
Routine HIV testing in the context of syndromic management of sexually transmitted infections: outcomes of the first phase of a training programme in Botswana (2008) (12)
Sexually Transmitted Infections and Associated Conditions Among Women Who Have Sex with Women (2009) (11)
Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial. (2019) (11)
Validity of self‐reported history of Chlamydia trachomatis infection (2017) (10)
Social Harms in Female-INITIATED hiv prevention method RESEARCH: state of the evidence. (2019) (10)
Barriers to Bacterial STI Testing of HIV-Infected Men who have Sex with Men Engaged in HIV Primary Care (2015) (10)
Addressing Standards of Care in Resource-Limited Settings (2014) (10)
Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection. (2016) (10)
Vaginal and Extra-Vaginal Bacterial Colonization and Risk for Incident Bacterial Vaginosis in a Population of Women Who Have Sex With Men (2020) (9)
Sexually Transmitted Infection Prevalence in Women With HIV: Is There a Role for Targeted Screening? (2018) (9)
HIV Prevention: Opportunities and Challenges. (2017) (9)
Sexually transmitted infections and female reproductive health (2022) (8)
Cervical Specimen Order and Performance Measures of Chlamydia trachomatis Diagnostic Testing (2005) (8)
Extracts from "Concise Clinical Evidence" (2002) (7)
Levels of Genital Tract Defensins and Cytokines Differ between HIV‐Uninfected US and African Women (2015) (7)
STIs Among Women Who Have Sex with Women (2017) (7)
Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in Southern California. (2022) (7)
Emerging issues in management of sexually transmitted diseases in HIV infection (2007) (7)
BIOMEDICAL PREVENTION OF HIV IN WOMEN: CHALLENGES AND APPROACHES, WITH PARTICULAR REFERENCE TO THE VAGINAL MICROBIOME. (2018) (7)
Differences in vaginal microbiota, host transcriptome and proteins in women with bacterial vaginosis are associated with metronidazole treatment response. (2021) (7)
Decreasing High Risk Exposures for Healthcare-workers through Universal Masking and Universal SARS-CoV-2 Testing upon entry to a Tertiary Care Facility (2020) (7)
Characteristics of female sexually transmitted disease clinic clients who report same-sex behaviour (2001) (6)
Chancroid: new developments in an old disease. (1995) (6)
Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization (2021) (6)
Sexually transmitted diseases in the HIV care setting: what's really going on down there? (2004) (6)
HIV Status and Other Risk Factors for Prevalent and Incident Sexually Transmitted Infection during Pregnancy (2000-2014) (2019) (6)
Improving HIV/STD prevention in the care of persons living with HIV through a national training program. (2014) (6)
Screening and management of genital chlamydial infections. (2013) (6)
Preferred characteristics of vaginal microbicides in women with bacterial vaginosis. (2009) (6)
Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals (2017) (6)
Expanding the spectrum of pathogens in urethritis: implications for presumptive therapy? (2007) (6)
Health Care Provider Perceptions of a Sexually Transmitted Infection Self-testing Program in an HIV Care Clinic (2017) (5)
HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies (2021) (5)
Impact of new sexually transmitted disease diagnostics on clinical practice and public health policy (2001) (5)
Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial. (2017) (5)
Cesarean delivery in women with genital herpes in washington state, 1989-1991. (1997) (5)
A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds. (2015) (5)
O3-S5.04 The post-trial effect of periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and Lactobacillus colonisation (2011) (4)
What's new in sexually transmitted infections in the HIV care setting: focus on syphilis and gonorrhea. (2014) (4)
Intersecting Epidemics: Incident Syphilis and Drug Use in Women Living with HIV in the United States (2005-2016). (2019) (4)
Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls. (2020) (4)
Sexually Transmitted Infection Prevalence Among Women at Risk for HIV Exposure Initiating Safer Conception Care in Rural, Southwestern Uganda (2020) (4)
Characterizing HIV-preventive, plasma tenofovir concentrations. A pooled participant-level data analysis from HIV pre-exposure prophylaxis (PrEP) clinical trials. (2022) (4)
Cost-Effectiveness Analysis (2007) (4)
Impact of the menstrual cycle and ethinyl estradiol/etonogestrel contraceptive vaginal ring on granulysin and other mucosal immune mediators (2021) (4)
Annals On Call - Protecting Health Care Workers From COVID-19. (2020) (4)
High rates of persistent and recurrent chlamydia in pregnant women after treatment with azithromycin (2020) (4)
Lenacapavir for HIV-1 - Potential Promise of a Long-Acting Antiretroviral Drug. (2022) (3)
Sexually Transmitted Infections and Associated Conditions Among Women Who Have Sex with Women~!2009-06-10~!2009-08-01~!2009-12-24~! (2010) (3)
American Sexually Transmitted Diseases Association and the Thomas Parran Award: past, present, and future. (2013) (3)
Genetic Variation in Toll-Like Receptor 5 and Colonization with Flagellated Bacterial Vaginosis-Associated Bacteria (2020) (3)
Tenofovir-Based Pre-exposure for HIV Infection among African Women (2014) (3)
Prevalence of and Factors Associated with Genital and Extragenital Chlamydia and Gonorrhea among Transgender Women in HIV Care in the United States; 2005-2016. (2020) (3)
Elusive aetiology of bacterial vaginosis. Do lesbians have a clue? (2007) (3)
Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities. (2019) (3)
A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV‐negative women planning for or with pregnancy in rural Southwestern Uganda (2022) (3)
Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data (2020) (3)
Faculty Opinions recommendation of Anorectal and inguinal lymphogranuloma venereum among men who have sex with men in Amsterdam, The Netherlands: trends over time, symptomatology and concurrent infections. (2014) (3)
Enhancing Women’s Sexual Health: Prevention Measures in Diverse Populations of Women (2013) (2)
Advancing Care for Lesbian, Gay, Bisexual, and Transgender Persons: Enough Already? (2015) (2)
O18.2 Injectable progestin contraception and acquisition of hsv-2 infection among south african women participating in the voice trial (2015) (2)
P239 Genital HSV-2 suppression is not associated with alterations in the vaginal microbiome: a one-way, cross-over study (2019) (2)
Evaluation of the National Sexually Transmitted Disease Curriculum: Reach, Utilization, and Engagement. (2020) (2)
The cost-effectiveness of screening men for Chlamydia trachomatis (2008) (2)
Faculty Opinions recommendation of The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study. (2014) (2)
O08.3 Barriers to Bacterial STI Screening of HIV+ Men Who Have Sex with Men (MSM) in HIV Primary Care Settings (2013) (2)
Chapter 18 – Bacterial Vaginosis (2013) (2)
P420 Understanding PrEP service delivery preferences among black women in urban and rural counties in the US deep south (2019) (2)
Correction: Performance of Swabs, Lavage, and Diluents to Quantify Biomarkers of Female Genital Tract Soluble Mucosal Mediators (2012) (2)
Barriers to Infectious Disease Prevention among Women (2004) (2)
O14.1 Bacterial Vaginosis-Associated Bacteria (BVAB) and Non-Gonococcal Urethritis (NGU) (2013) (2)
Even NHANES evolves: Some surprising findings about women who have sex with women. (2010) (2)
Bacterial STI screening among women living with HIV in the southeastern united states: 27 (2017) (2)
Azithromycin versus Penicillin for Early Syphilis (2005) (2)
Sexually Transmitted Diseases (2006) (2)
EXECUTIVE SUMMARY Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba. (2022) (2)
Dangerous assumptions: lesbians and sexual death [editorial] (2005) (2)
Faculty Opinions recommendation of Proportion of Incident HIV Cases among Men Who Have Sex with Men Attributable to Gonorrhea and Chlamydia: A Modeling Analysis. (2019) (2)
Cervicitis: Balancing the Goals of Empiric Therapy and Antimicrobial Stewardship to Improve Women's Health. (2020) (2)
P588 A multi-site comparative study to understand sources of variability in studies of the vaginal microbiota (2019) (1)
What’s Old Is New: the Evolution of Lymphogranuloma Venereum Proctitis in Persons Living with HIV (2022) (1)
Track C Epidemiology and Prevention Science (2012) (1)
Diagnosis and Management of Bacterial Vaginosis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. (2022) (1)
HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights (2017) (1)
53 – Introduction to Sexually Transmitted Infections (2011) (1)
Cesarean Delivery in Women With Genital Herpes in Washington State, 1989–1991 (1997) (1)
Surgery during the COVID-19 pandemic: Don't wait to vaccinate (2022) (1)
ECHO: context and limitations (2020) (1)
Molecular Characterization of Microbes in the Female Upper Genital Tract: A Valiant Quest to "Redefine" Pelvic Inflammatory Disease. (2021) (1)
Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa (2021) (1)
Evaluation of the National STD Curriculum: Reach, Utilization, and Engagement. (2020) (1)
Heterosexual anal intercourse practices and associated HIV risk in two recent cohort studies in Eastern and Southern Africa (2018) (1)
P369 Incidence of vaginal infections in kenyan women randomized to continuous or cyclic contraceptive ring (CVR) (2019) (1)
Editorial commentary: Sexual networks, sex hormones, and recurrent bacterial vaginosis: not such strange bedfellows. (2013) (1)
‘I still desire to have a child’: a qualitative analysis of intersectional HIV- and childlessness-related stigma in rural southwestern Uganda (2022) (1)
Chapter 41 – Sexually Transmitted Infections and Foreign Travel (2017) (1)
Behavioral Counseling for Sexually Transmitted Infection Risk Reduction. (2020) (1)
Correlates of sexually transmitted infections in young women. (2007) (1)
Screening for Chlamydia and Gonorrhea. (2021) (1)
7. Bacterial Vaginosis (2012) (1)
Syphilis? An Unusual Cause of Surgical Emergency in a Human Immunodeficiency Virus-Infected Man (2015) (1)
O05.3 More Than Meets the Eye: A Molecular Phylogenetic Analysis Reveals Importance of Novel Bacteria in Bacterial Vaginosis (BV) (2013) (1)
Reply to Forney et al. (2006) (1)
1282. A Major Hurdle for HIV Elimination: How Do We Promote Pre-Exposure Prophylaxis Persistence among Men Who Have Sex with Men in the Deep South? (2019) (1)
An Ulcer by Any Other Name: Non-herpes and Non-syphilis Ulcerative Sexually Transmitted Infections. (2023) (0)
Preface. (2023) (0)
Fellows' Day Program Continued (2005) (0)
Genital Herpes Simplex Virus Type 2 Suppression With Valacyclovir Is Not Associated With Changes in Nugent Score or Absolute Abundance of Key Vaginal Bacteria (2023) (0)
01 / PREVALENCE OF CHLAMYDIA, GONORRHEA AND RISK BEHAVIORS AMONG WOMEN LIVING WITH HIV IN THE UNITED STATES; 2007-2016 (2018) (0)
02 / HIGH RATE OF EXCLUSION FOR BACTERIAL VAGINOSIS (BV) RESEARCH IN WOMEN SCREENED WITH TRADITIONAL CLINICAL CRITERIA IN KENYA: NEED FOR MOLECULAR DIAGNOSTICS? (2018) (0)
219. A Randomized, Double-Masked, Placebo-Controlled Phase IIB Trial of Azithromycin and Trimethoprim-Sulfamethoxazole as Bacterial STI Prophylaxis in Pregnant Women with HIV (2022) (0)
Screening for Syphilis in Nonpregnant Adults and Adolescents. (2022) (0)
Review: Self-collected samples are less accurate for HPV testing than clinician-collected samples (2014) (0)
Faculty Opinions recommendation of Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. (2014) (0)
Recent Developments in Biomedical Issues in Sexually Transmitted Infections: Implications for Behavioral Parameters of Interest. (2018) (0)
Chapter 38 – Gonococcal and Chlamydial Genital Infections, and Pelvic Inflammatory Disease (2008) (0)
P728 Correlates of syphilis in women living with and without HIV in the US women’s interagency HIV study (WIHS) (2019) (0)
Faculty Opinions recommendation of Rate and predictors of repeat Chlamydia trachomatis infection among men. (2014) (0)
Microbicides—Where Are We? (2015) (0)
5 – Vaginal Infections (2010) (0)
Faculty Opinions recommendation of Failure of dual antimicrobial therapy in treatment of gonorrhea. (2018) (0)
Still at Highest Risk: Innovative Approaches & Urgent Needs for Prevention and Care (2018) (0)
Prevalence, Incidence & Predictors of Treatment Failure for Bacterial Vaginosis (BV) (2006) (0)
POST-Conference Workshop: STD/HIV Prevention in the HIV Care Setting (2005) (0)
A Practical Update on Sexually Transmitted Infections: Advances in Diagnosis and Treatment (2003) (0)
T Cell Responses in Humans + CD 8-Reactive Chlamydia Non-Class Ia-Restricted Functional Characterization of Class Ia-and Marrazzo (2003) (0)
Debate 1: Countries Should Start Control Programs for Trichomonas Vaginalis NOW (2014) (0)
O04.3 Uptake and acceptability of contraceptive vaginal ring among women with bacterial vaginosis in kenya (2017) (0)
S11.1 Introduction to the vaginal microbiome pre-conference symposium (2019) (0)
Cervicitis and PID (2006) (0)
Annals On Call - Diagnosing SARS-CoV-2 Infection: Symptoms or No Symptoms? (2020) (0)
Faculty Opinions recommendation of Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. (2014) (0)
15: Relationship of specific bacteria in the cervical and vaginal microbiotas with cervicitis (2015) (0)
Update on the HIV Prevention and Care Cascade (2017) (0)
Faculty of 1000 evaluation for Zika virus shedding in semen of symptomatic infected men. (2018) (0)
Time 101: Optimizing Meetings (2018) (0)
Holistic Management of Patients with HIV (2017) (0)
Chlamydia trachomatis infection among sexual minorities (2013) (0)
Population-level correlation between incidence of curable sexually transmitted infections and HIV-1 among African women participating in HIV-1 pre-exposure prophylaxis trials. (2022) (0)
Selected Abstracts (2001) (0)
John F. Enders Lecture (2018) (0)
Faculty Opinions recommendation of Speaking out about gender imbalance in invited speakers improves diversity. (2018) (0)
P587 Association between vaginal bacteria and HIV acquisition risk among african women participating in the VOICE study (2019) (0)
Faculty Opinions recommendation of Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. (2014) (0)
5: Injectable progestin contraception and vaginal infection among south african women participating in the VOICE trial (2015) (0)
Chapter 37 – Sexually Transmitted Infections and Foreign Travel (2008) (0)
Preventing HIV, STI, and Unintended Pregnancy in Women at Risk: Evolving Evidence and Approach (2016) (0)
Topical Prevention of STI & HIV: Advances & Controversies (2018) (0)
Sexually Transmitted Infections (2023) (0)
Elevated rates of persistent and recurrent chlamydia infection in pregnancy: 638 (2019) (0)
High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study (2023) (0)
Effectiveness and Patient Acceptability of a Self-Testing Intervention for STI in an HIV Primary Care Setting (2014) (0)
P387 STI incidence after STI treatment among women at risk for HIV exposure initiating safer conception care in southwestern Uganda (2021) (0)
Syphilis in Women (2013) (0)
The association between heterosexual anal intercourse and HIV acquisition in three prospective cohorts of women (2022) (0)
S16.2 Recurrent BV (2013) (0)
P3.363 Inflammatory Soluble Immune Mediators and Pathogenic Vaginal Bacteria Impact E. Coli Bactericidal Activity in Female Genital Tract Secretions (2013) (0)
Clinical Features Associated with Detection of Novel Bacterial Vaginosis-Associated Bacteria (BVAB) (2005) (0)
Sexually transmitted infections. Preface. (2013) (0)
Challenges in STD Management: What Don't the Guidelines Tell Us? (2009) (0)
The vaginal flora of healthy women is not always dominated by lactobacillus species [letter] [reply] (2006) (0)
TUPDC0103: Gonorrhea infections diagnosed among persons living with HIV: cross matching surveillance registries to identify potential opportunities for integrated partner services-New York City, Washington D.C., Miami/Dade County and Arizona (2012) (0)
HIV Prevention: PrEP and Beyond (2016) (0)
65 – Management of Gonorrhea (2017) (0)
A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. (2017) (0)
P2.11 Association between genital herpes simpex virus type-2 shedding and presence of bacterial vaginosis-associated bacteria (2017) (0)
P334 Acceptance of contraceptive vaginal ring among women with bacterial vaginosis and their male partners in kenya (2019) (0)
The Human Microbiome in HIV (2018) (0)
Audio Interview: Communicating Covid-19 Science. (2022) (0)
HIV Prevention 2017 (2017) (0)
7: Relationships between host innate immune genetic variation, bacterial vaginosis, and bacterial colonization (2016) (0)
Managing prevalent and problematic sexually transmitted infections (2013) (0)
21 Cost-Effectiveness Analysis (2007) (0)
23 – Syphilis in Women (2000) (0)
Topical Microbicides for Human Immunodeficiency Virus and Sexually Transmitted Disease Prevention (2013) (0)
Introduction: HIV Prevention in the Care Setting (2007) (0)
Faculty of 1000 evaluation for The Swedish new variant of Chlamydia trachomatis. (2014) (0)
Diagnosis of Bacterial Vaginosis: Diagnostic Challenges (2018) (0)
So You Think You Know Everything About STDs? What's New, Exciting, and Essential for Management, 2005 (2005) (0)
The State of the HIV Care Landscape (2016) (0)
Multipurpose Prevention Technologies: A Game-Changer for STI Prevention (2014) (0)
A publication of the International AIDS Society–USA Perspectives HIV Infection in Women: Perinatal Issues and 1 Cervical Cancer Surveillance (2007) (0)
Faculty Opinions recommendation of Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. (2014) (0)
Cesarean Delivery in Women With Genital Herpes (1997) (0)
S16.4 Designing an approach to deal with extragenital sexually transmitted infections: do we have the data we need? (2019) (0)
Infections caused by Clostridium perfringens and Paeniclostridium sordellii after unsafe abortion. (2022) (0)
Superficial hepatic capsular lesions in a systemically ill young woman. (2007) (0)
1527. Incident Sexually Transmitted Infections among Southern Men Who Have Sex with Men Living with HIV in the Era of Biomedical Prevention (2020) (0)
Chapter 42 – Gonococcal and Chlamydial Genital Infections and Pelvic Inflammatory Disease (2017) (0)
Faculty Opinions recommendation of Prevalence of rectal chlamydial and gonococcal infections: A systematic review. (2018) (0)
Genetic variation of lactobacilllus crispatus strains isolated from a woman during and after bacterial vaginosis: 24 (2018) (0)
Testing for & Treating Sexually Transmitted Infections: Who, What, When, Where, & How? (2014) (0)
“My hair is falling out, and they told me I have syphilis!” (2020) (0)
Sexually transmitted diseases in the HIV care setting (2004) (0)
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply. (2015) (0)
Preventing and Identifying New HIV Infections (2017) (0)
HIV Prevention and Diagnosis (2016) (0)
Contributors (2015) (0)
II. Incorporating HIV Prevention into the HIV Care Setting Streamlined Behavioral and Clinical Risk Assessing for the Busy HIV Care Practitioner: Screening: How, When, and Why (2005) (0)
Challenging HIV Cases (2017) (0)
Improving Health with Key HIV Populations (2016) (0)
STI prevalence, incidence, and partner notification among women in a periconception HIV prevention program in Uganda (2022) (0)
Factors associated with syphilis seroprevalence in women with and at-risk for HIV infection in the Women’s Interagency HIV Study (1994–2015) (2021) (0)
FULL TECHNICAL REPORT Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba. (2022) (0)
Factors associated with awareness about syphilis and gonorrhoea among women in Bangladesh (2017) (0)
PrEP service delivery preferences of black Cis-gender women living in the Southern United States (2022) (0)
Bacterial STI Incidence among Southern MSM Living with HIV in the Treatment as Prevention Era, 2014-2019. (2022) (0)
Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis (2022) (0)

This paper list is powered by the following services:

Other Resources About Jeanne Marrazzo

en.wikipedia.org

What Schools Are Affiliated With Jeanne Marrazzo?

Jeanne Marrazzo is affiliated with the following schools:

Jeanne Marrazzo's Academic­Influence.com Rankings